The aim of this study was to evaluate the hemodynamic performance of a sutureless bioprosthesis under high workload at mid-term follow-up.
cross-clamping time. The Perceval sutureless bioprosthesis (LivaNova Biomedica Cardio Srl, Saluggia, Italy) demonstrated excellent immediate results in patients at intermediate operative risk. [1] [2] [3] However, hemodynamics of this valve prosthesis has been described in vivo only at rest and, to the best of our knowledge, there are no data on the hemodynamic performance of Perceval sutureless bioprosthesis under high workload conditions at mid-term follow-up. We sought to compare follow-up echocardiographic findings of Perceval sutureless bioprosthesis to preoperative and discharge records, and to evaluate the valve hemodynamics at rest and under stress at mid-term follow-up.
| METHODS
From April 2011 to June 2015, a Perceval sutureless bioprosthesis (LivaNova Biomedica Cardio Srl) was implanted in 106 consecutive patients with a preoperative diagnosis of severe symptomatic aortic stenosis with or without associated aortic regurgitation of any grade.
Other major concomitant cardiac procedures (coronary surgery, septal myectomy, mitral valve repair, tricuspid valve repair) were performed when needed.
Indications for the implantation of a sutureless bioprosthesis were as follows: elderly patients with multiple comorbidities, frailty, and increased operative risk as estimated by EuroSCORE II score; patients with small annulus and/or calcified aortic root. 4 Preoperative patient's frailty was graded according to the CSHA scale. 5 The implantation of this valve was considered feasible when the aortic annular size was between 19 mm and 27 mm and ratio between the sinotubular diameter and that of the aortic annulus was less than The technique of implantation has been previously described. 1 In all patients, the aortic annulus was completely decalcified. No attempt to enlarge the annulus has been made, according to the manufacturer's instruction. The annulus was measured with appropriate sizers, and the valve size was chosen according to intraoperative measurements.
Three 4-0 polypropylene guiding sutures were passed at the nadir of each sinus and then inside the green eyelets to help parachuting the prosthesis valve in the correct position. Once the prosthesis valve was in place, it was ballooned at 4 atmospheres for 30 seconds while the field was rinsed with warm saline. 1 Institutional Review Board approved the study and informed consent was obtained from each patient. As this patient population included mainly elderly and fragile patients, who were unable to adequately perform an exercise protocol, we decided to perform a pharmacological stress instead of a physical test to avoid any potential bias regarding the inability to conclude the test due to muscular fatigue. At the end of the test, dobutamine infusion was discontinued and patients were monitored for at least 20 minutes or until heart rate returned to pretest values. 
| RESULTS
Transvalvular gradients and valve area at discharge significantly im- T A B L E 1 (Continued)
24.4 ± 7.8 mm Hg, P = .69; mean gradient 12.5 ± 4.1 vs 12.6 ± 4.4, P = .90).
Effective orifice area index (EOAi) was ≤0.65 cm 2 /m 2 in eight patients (25%), without any difference in terms of NYHA functional class (1.6 ± 0.5 vs 1.4 ± 0.5, P = .31).
All patients were able to complete the test without adverse events (Table 2) . Heart rate and stroke volume significantly increased with DSE. At maximal stress, peak and mean transvalvular gradients significantly increased from baseline, but never reaching a mean gradient of 40 mm Hg, which is a cutoff suggestive of an iatrogenic aortic stenosis.
Similarly, EOA, EOAi (Figure 1) , and DVI increased significantly. EOA(i) = effective orifice area (index); DVI = dimensionless velocity index.
| DISCUSSION
Assessment of prosthetic valve function is usually performed at rest after AVR. However, increasing gradients under high workload conditions are not an uncommon finding, particularly in case of narrow aortic annuli, unless aortic annular enlargement is performed.
10,11
Accordingly, exercise echocardiography or DSE may unveil a prosthetic valve dysfunction otherwise overlooked at rest.
Several reports confirmed the equipoise of both techniques for the hemodynamic evaluation of aortic valve prosthesis. 12, 13 However, the aim of this study was to assess valve hemodynamics at increased workload, independently from the occurrence of dyspnea during physical exercise. Accordingly, in the present study, we preferred the DSE to exercise test, to avoid the potential bias of an incomplete exercise test. Besides the inherent benefits of reducing aortic cross-clamping time, Perceval sutureless bioprosthesis became the valve of choice for elderly, fragile patients at our institution ( Table 1 ).
The reliability of the Perceval sutureless bioprosthesis for aortic valve replacement has been already demonstrated. [1] [2] [3] Initially, this valve prosthesis was implanted mostly in very elderly or in those patients with severe comorbidities. Indeed, patients enrolled in the present study were older, more fragile, with a higher expected operative risk compared with a contemporary cohort of patients receiving stented valve. Later on, the use of this bioprosthesis was found valuable in minimally invasive surgery also in lower risk patients. [14] [15] [16] When valve performance at rest is concerned, we observed similar results compared with other recently studies, either in terms of peak and mean gradients or in terms of EOA 17, 18 also when compared to a propensity-matched cohort of patients undergoing TAVI. 19 On the other hand, we observed slightly higher gradients in our multicenter
European cohort of patients undergone AVR with Perceval sutureless bioprosthesis compared with a multicenter TAVI Italian experience (ITER registry). 20 Therefore, a hemodynamic comparison between
Perceval sutureless bioprosthesis and TAVI is still a matter of concern and further studies are needed to confirm these results.
Because of the widespread use of this valve bioprosthesis, particularly in an increasing number of physically active patients, the assessment of its hemodynamic performance under high workload conditions is of clinical relevance. In the present study, we observed increased transvalvular gradients during DSE as a result of increased heart rate and stroke volumes. This is a general finding when the performances of aortic prostheses are investigated under stress. Offstad et al. 21 reported a 134% increase in mean transvalvular gradients at peak stress in a cohort of patients receiving mechanical prostheses.
Similarly, Minardi assessed the hemodynamic of 19 patients receiving small-sized 17-mm St. Jude Medical Regent mechanical prostheses.
Interestingly, despite a significant improvement in functional classes at 36 ± 12 month follow-up, most of patients developed at least mild PPM, with significant increase in mean prosthetic gradients, reaching an average of 42.3 ± 12.7 mm Hg. 22 Increasing transvalvular gradients under DSE have been reported also by Sezai et al. 23 on 58 patients undergone AVR with all sizes of St. Jude Medical Regent prosthesis. In particular, 10.3% of patients have PPM without clinical significance in the early and mid-term follow-up. 23 Interestingly, Khoo et al. 24 reported on the hemodynamic better performance of stentless over stented prostheses. These authors showed that stentless valve prostheses perform similarly to mildly stenosed native aortic valves under stress, whereas stented and mechanical prostheses resembled the performances of mild-to-moderate stenosis. Repossini et al. 25 described an increase in mean transvalvular gradients during exercise in patients undergone AVR with the Freedom SOLO bioprosthesis. These results are in part expected, because a mechanical valve cannot accommodate larger stroke volumes, therefore, resulting in increased gradients. On the other hand, bioprostheses can modulate leaflet motion according to stroke volumes, thus resulting in increased EOA with only slight rise in transprosthetic gradients.
In the present study, we observed a significant increase in EOA, EOAi, and DVI under stress. This is in contrast with the findings of Silberman et al., 26 who failed to detect any differences in EOAi under stress for stented, stentless bioprostheses, and mechanical valves.
On the other hand, Hanke and coworkers reported increased EOAi in patients undergone exercise stress after AVR with Trifecta stented bioprosthesis, Ross operation, and in a control group of healthy volunteers, but not in those patients who received a stentless Freestyle valve. 27 Similarly, Bach and associates demonstrated similar hemodynamics at rest and during exercise between stented Trifecta and stentless Freedom bioprostheses, being both valves superior to Magna Ease in terms of peak velocity, mean gradient, and EOA. 28 Furthermore, Repossini et al. 25 reported an increase in EOA from 1.7 ± 0.3 cm 2 to
1.8 ± 0.4 cm 2 at exercise stress echocardiography. When these last results are compared with the findings of our study, we observed a significantly greater increase in EOA at DSE, reaching 2.1 ± 0.7 cm 2 at peak stress. These findings should be viewed in light of technical and methodological differences between these studies. First, although exercise and dobutamine stress test are equivalently effective for the evaluation of aortic valve prostheses, the two methodologies are not fully comparable. 12, 13 Second, despite a similar valve prosthesis profile, the Freedom Solo is a complete supra-annular stentless valve seated on the Valsalva sinuses, whereas the Perceval sutureless bioprosthesis is deployed in to the native aortic annulus and this might be responsible for different hemodynamics. It could be speculated that the nitinol struts might be responsible of increased transvalvular gradients T A B L E 4 Hemodynamic assessments during dobutamine stress echocardiography in patients with prosthesis-patient mismatch (n = 8) 33 recently demonstrated the satisfying performance of the S size Perceval sutureless bioprosthesis either at discharge or at early follow-up, further validating the excellent hemodynamic performance of the sutureless bioprosthesis in patient with small aortic annuli. 31, 32 These results suggest that the reliability of Perceval sutureless bioprosthesis even in patients with a small aortic annulus, or when a PPM could be anticipated preoperatively.
Furthermore, Blais et al. 11 demonstrated that mild-to-moderate PPM is not always an issue of clinical relevance. Finally, the Perceval sutureless bioprosthesis could be a valuable option for those patients with calcified aortic root, in whom any attempt to enlarge the annulus may endanger the outcome of these patients. 4, 34 A number of limitations related to this study should be acknowledged. First, the small sample size of this series is a clear limitation of this study. On the other hand, our results stem from the singlecenter design of the study, which guarantees uniformity of the surgical technique and of echocardiographic evaluations. Furthermore, in an attempt to better validate our hypothesis, we selected patients with at least 1-year follow-up to test also the hemodynamic performance of this valve prosthesis late after surgery. Second, the flow dependence of the EOA estimated by the continuity equation could be considered controversial, as the increased EOA might be the result of a mathematical effect without any anatomical implication. However, one of the major strength of this analysis is the strict inclusion criteria of these the patients. In particular, the exclusion of patients with severe left ventricular systolic dysfunction and/or mitral valve regurgitation prevented any bias of Doppler quantifications. Finally, the lack of a control group with stented bioprostheses prevents conclusive results on the hemodynamic benefits of the Perceval sutureless bioprosthesis in patients with small aortic annulus.
In conclusion, AVR with the Perceval sutureless bioprosthesis provides excellent hemodynamics at rest and under DSE. The significant increase in EOAi under DSE suggests the potential benefit of using the Perceval sutureless bioprosthesis in patients with small aortic annulus or when PPM is anticipated.
